Moneycontrol PRO
HomeNewsBusinessStocksQuick Take | Monsanto wins legal battle for BT cotton seed technology

Quick Take | Monsanto wins legal battle for BT cotton seed technology

SC has overturned a judgment by the Delhi High Court which held that certain items such as seeds, plants and animals cannot be patented under Indian laws.

January 08, 2019 / 14:10 IST
Representational image

Representational image

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Ruchi AgrawalMoneycontrol Research

Monsanto’s subsidiary Mahyco Monsanto Biotech (MMBL) has won a legal battle against Nuziveedu seeds to own patents on genetically modified (GM) cotton seeds in India. The Supreme Court has ruled that Monsanto’s patent for BT cotton seeds is valid, overturning a judgment by the Delhi High Court which held that certain items such as seeds, plants and animals cannot be patented under Indian laws.

The ruling comes after years of legal battle between Monsanto and domestic seed companies. While Monsanto had cleared disputes with three domestic companies including Kaveri Seeds, Ankur Seeds and Ajeet Seeds, eight other domestic players including Nuziveedu Seeds, Prabhat Agri Biotech, Pravardhan Seeds, Amar Biotech, Sri Rama Agri Genetics and others had refused to clear dues of Rs 450 crore.

While the judgement is positive for Monsanto that had been battling to get royalties for its BT cotton seed technology, it could mean an uptick in costs for domestic seed players due to higher pricing freedom to Monsanto and continued royalty payments. This could mean lower margins for companies, seed scarcity in domestic markets and could also give way to spurious seeds, negatively impacting yields.

Domestic companies get a license from Monsanto to sell GM seeds in exchange for a trait fee fixed by the government. This fee was reduced from Rs 49 per packet to Rs 39 per packet last year. Monsanto has pending cases against fixing the cotton price and trait fee by the government and the current ruling might strengthen Monsanto’s claims.

Though on the one hand, it means higher costs for domestic seed players, on the other, the judgement also stands to boost the confidence of global players about the validity of patents in India. Biotech companies may resuscitate their plans of expansion in India, put on hold following several restrictions imposed by the Indian government.

Moreover, amid the royalty row and patent infringement, Monsanto had refrained from introducing the latest Bollgaurd-3 technology in India and the cotton production had witnessed severe pink bollworm attacks. The court’s ruling might lead to the introduction of new technology in the country by global biotech giants.

Follow @Ruchiagrawal

For more research articles, visit our Moneycontrol Research Page.

Ruchi Agrawal
first published: Jan 8, 2019 02:01 pm

Disclosure & Disclaimer

This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347